Correlation of Specific Inflammatory Markers With the Occurrence of Depression in Patients With Psoriasis and Their Use as Biomarkers for the Diagnosis Of Depression
Keywords:
psoriasis, depression, pathophysiology, inflammation, CRP, ESRAbstract
Introduction: Psoriasis is a systemic disease of the skin and nails associated with a wide range of comorbidities such as depression, psoriatic arthritis and metabolic syndrome.
Objective: The study aimed to examine a potential association between inflammatory markers (CRP, ESR) and depression in patients with psoriasis.
Material and methods: A total of 80 individuals were enrolled in the study. Case participants included 28 patients diagnosed with Psoriasis (Beck Depression Inventory-II: :0-13) and 24 patients diagnosed with Psoriasis and Depression (Beck Depression Inventory-II:14-63). Twenty-eight (28) healthy participants comprised the control group.
Psoriasis severity was evaluated by using Psoriasis Area and Severity Index, Physician Global Assessment, Body Surface Area and Dermatology Life Quality Index . Written approval was obtained for its use in this study: Cardiff University (09/2015). Other factors considered in the study were obesity using the Body Mass Index, the levels of stress using the Beck Anxiety Inventory, and the presence of insomnia using the Athens Insomnia Scale . Blood draws and inflammatory markers measurements were performed for all participants.
Results: Both CRP and ESR levels were higher in the case group (i.e. Psoriasis and Depression and Psoriasis) compared to healthy controls. Furthermore, psoriatic patients with depression showed increased CRP and ESR levels compared to those of psoriatic patients without depression.
Conclusions: The evaluation of both CRP and ESR and their use to detect the presence of depression in patients with psoriasis can be an important tool for their holistic treatment of theirs.
References
Global report on psoriasis, World Health Organization 2016
www.the lancet.com vol 397 april3, 2021
Ling Chen & Zhu Shen, Tissue-resident memory T cells and their biological characteristics in the recurrence of inflammatory skin disorders, Cellular & Molecular Immunology volume 17, pages64–75 (2020)
Palijan TZ , Kovacević D, Koić E, Ruzić K, Dervinja F. The impact of psoriasis on the quality of life and psychological characteristics of persons suffering from psoriasis. Coll Antropol. 2011 Sep;35 Suppl 2:81-5.
Han C , Lofland JH, Zhao N, Schenkel B. Increased prevalence of psychiatric disorders and health care associated costs among patients with moderate to severe psoriasis. J Drugs Dermatol. 2011 Aug;10(8):84350
Gowda S, Goldblum OM, McCall WV, Feldman SR. Factors affecting sleep quality in patients with psoriasis. J Am Acad Dermatol. 2010 Jul;63(1):114-23.
Shutty BG , West C, Huang KE, Landis E, Dabade T, Browder B, O'Neill J, Kinney MA, Feneran AN, Taylor S, Yentzer B, McCall WV, Fleischer AB Jr, Feldman SR. Sleep disturbances in psoriasis. Dermatol Online J. 2013 Jan 15;19(1):1.
Eskin M1, Savk E, Uslu M, Küçükaydoğan N. Social problem-solving, perceived stress, negative life events, depression and life satisfaction in psoriasis. J Eur Acad Dermatol Venereol. 2014 Nov;28(11):1553-9.
Dowlatshahi EA , Wakkee M , Arends LR , Nijsten T. The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and metaanalysis. J Invest Dermatol. 2014 Jun;134(6):154251.
Bangemann K , Schulz W, Wohlleben J, Weyergraf A, Snitjer I, Werfel T, SchmidOttG, Böhm D. Depression and anxiety disorders among psoriasis patients: Protective and exacerbating factors. Hautarzt. 2014 Dec;65(12):105661.
Kurd SK , Troxel AB, CritsChristoph P, Gelfand JM. The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol. 2010 Aug;146(8):8915
Wiebke Sondermann , Oliver Fiege , Andreas Körber , Norbert Scherbaum Psychological burden of psoriatic patients in a German university hospital dermatology department, J Dermatol. 2021 Jun;48(6):794-806
Albert Duvetorp, Ulrich Mrowietz, Mats Nilsson, Oliver Seifert, Sex and Age Influence the Associated Risk of Depression in Patients with Psoriasis: A Retrospective Population Study Based on Diagnosis and Drug-Use, Dermatology. 2021;237(4):595-602
Chanyang Min, Miyoung Kim, Dong Jun Oh, Hyo Geun Choi, Bidirectional association between psoriasis and depression: Two longitudinal follow-up studies using a national sample cohort, J Affect Disord. 2020 Feb 1; 262:126-132.
Georgia Lada , Hector Chinoy , Peter S Talbot , Richard B Warren , C Elise Kleyn , The effect of the Covid-19 pandemic on illness perceptions of psoriasis and the role of depression: Findings from a cross-sectional study, Skin Health Dis. 2022 Jul 3;2(3):e145.,
Qiaolin Wang et al, Nonadherence to Treatment and Patient-Reported Outcomes of Psoriasis During the COVID-19 Epidemic: A Web-Based Survey, Patient Prefer Adherence. 2020 Aug 7; 14:1403-1409
Tarun Narang , Adhyatm Bhandari , Hitaishi Mehta , Kavita Narang , Sanjeev Handa , Sunil Dogra, Effect of Lockdown Due to COVID-19 on Health and Lifestyle of Psoriasis Patients: A Web-Based Survey, Indian Dermatol Online J. 2022 Sep 5;13(5):625-628.
Postal M, Appenzeller S. The importance of cytokines and autoantibodies in depression. Autoimmun Rev. 2015 Jan;14(1):30-35.
Bai YM, Su TP, Li CT, Tsai SJ, Chen MH, Tu PC, Chiou WF. Comparison of pro-inflammatory cytokines among patients with bipolar disorder and unipolar depression and normal controls. Bipolar Disord. 2015 May;17(3):269-77.
Audet MC, McQuaid RJ, Merali Z, Anisman H. Cytokine variations and mood disorders: influence of social stressors and social support. Front Neurosci. 2014 Dec 16;8:416.
Momeni M, Ghorban K, Dadmanesh M, Hajebrahimi B, Khodadadi H, Hassanshahi G, Arababadi MK. Differential pattern of cytokine production by depressed medical students, evidence for involvement of cytokine network in pathology of depression. Clin Lab. 2014;60(3):435-40.
Dahl J, Ormstad H, Aass HC, Malt UF, Bendz LT, Sandvik L, Brundin L, Andreassen OA. The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery. Psychoneuroendocrinology. 2014 Jul;45:77-86.
Chocano-Bedoya PO, Mirzaei F, O'Reilly EJ, Lucas M, Okereke OI, Hu FB, Rimm EB, Ascherio A. C-reactive protein, interleukin-6, soluble tumor necrosis factor α receptor 2 and incident clinical depression. J Affect Disord. 2014 Jul; 163:25-32.
Kannan S, Heller MM, Lee ES, Koo JY. The role of tumor necrosis factor-alpha and other cytokines in depression: what dermatologists should know. J Dermatolog Treat. 2013 Apr;24(2):14852.
Young JJ, Bruno D2, Pomara N. A review of the relationship between proinflammatory cytokines and major depressive disorder. J Affect Disord. 2014 Dec 1; 169:15-20.
Momeni M, Ghorban K, Dadmanesh M, Hajebrahimi B, Khodadadi H, Hassanshahi G, Arababadi MK. Differential pattern of cytokine production by depressed medical students; evidence for involvement of cytokine network in pathology of depression. Clin Lab. 2014;60(3):435-40
Wei TQ, Kramer S, Chu VP, Hudson D, Kilgore D, Salyer S, Parker G, Eyberger A, Arentzen R, Koiv H. An improved automated immunoassay for C-reactive protein on the Dimension clinical chemistry system. J Autom Methods Manag Chem. 2000;22(5):125-31
Luiza Marek-Jozefowicz 1,* , Rafał Czajkowski 1 , Alina Borkowska 2 , Bogusław Nedoszytko 3,4 , Michał A. Zmijewski ˙ 5 , Wiesław J. Cubała 6 and Andrzej T. Slominski 7,8 The Brain–Skin Axis in Psoriasis—Psychological, Psychiatric, Hormonal, and Dermatological , Aspects, Int. J. Mol. Sci. 2022, 23, 669.
Fredriksson T, Pettersson U. Severe psoriasis--oral therapy with a new retinoid. Dermatologica. 1978;157(4):238-44
C. Bonifati, E. Berardesca, Clinical outcome measures of psoriasis. Reumatismo. 59 (Suppl 1) (2007) 64–67.
Feldman SR, Krueger GG. Psoriasis assessment tools in clinical trials. Ann Rheum Dis. 2005 Mar
Robinson, M. Kardos, A.B. Kimball, Physician Global Assessment (PGA) and Psoriasis Area and Severity Index (PASI): why do both? A systematic analysis of randomized controlled trials of biologic agents for moderate to severe plaque psoriasis, J. Am. Acad. Dermatol. 66 (3) (2012) 369–375
P.I. Spuls , L.L. Lecluse , M.L. Poulsen , J.D. Bos , R.S. Stern, T. Nijsten, How good are clinical severity and outcome measures for psoriasis?: quantitative evaluation in a systematic review, J. Invest. Dermatol. 130 (4) (2010) 933–943
A. Bożek, A. Reich, The reliability of three psoriasis assessment tools: Psoriasis area and severity index, body surface area and physician global assessment, Adv. Clin. Exp. Med. 26 (5) (2017) 851–856
Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994 May;19(3):210-6.
A.T. Beck, R.A. Steer, G.K. Brown, Beck Depression Inventory: second edition manual, The Psychological Corporation, San Antonio TX, 1996
M. Giannakou, P. Roussi, M.E. Kosmides, G. Kiosseoglou, A. Adamopoulou, G. Garyfallos, Adaptation of the beck depression inventory-II to greek population, Hellenic Journal of Psychology 10 (2) (2013) 120–146.
Body mass index (BMI) - World Health Organization
WHO BMI CALCULATOR, HOW TO CALCULATE YOUR BODY MASS https://whobmicalculator.com
A. Kyriakou,A. Patsatsi,D. Sotiriadis,D.G. Goulis ,Adipokines in psoriasis ,British Journal of Dermatology, 179, 273–281 2018
S. Coimbra,C. Catarino,A. Santos-Silva, The triad psoriasis–obesity–adipokine profile JEADV 2016, Buechler et al, Chemerin Isoforms and Activity in Obesity, Int. J. Mol. Sci. 2019, 20(5), 1128
Soldatos CR, Dikeos DG, Paparrigopoulos TJ. Athens Insomnia Scale: validation of an instrument based on ICD-10 criteria. J Psychosom Res. 2000 Jun;48(6):555-60.
Soldatos CR, Dikeos DG, Paparrigopoulos TJ. The diagnostic validity of the Athens Insomnia Scale. J Psychosom Res. 2003 Sep;55(3):263-7.
Gowda S, Goldblum OM, McCall WV, Feldman SR. Factors affecting sleep quality in patients with psoriasis. J Am Acad Dermatol. 2010 Jul;63(1):114-23.
Shutty BG , West C, Huang KE, Landis E, Dabade T, Browder B, O'Neill J, Kinney MA, Feneran AN, Taylor S, Yentzer B, McCall WV, Fleischer AB Jr, Feldman SR. Sleep disturbances in psoriasis. Dermatol Online J. 2013 Jan 15;19(1):1.
Aaron T. Beck, BAI, Beck anxiety inventory, manual (1990)
Wei TQ, Kramer S, Chu VP, Hudson D, Kilgore D, Salyer S, Parker G, Eyberger A, Arentzen R, Koiv H. An improved automated immunoassay for C-reactive protein on the Dimension clinical chemistry system. J Autom Methods Manag Chem. 2000;22(5):125-31.
International Council for Standardization in Hematology ( Expert Panel on Blood Rheology ), ICSH recommendation for measurement of erythrocyte sedimentation rate, JClin Pathol 1993 Mar;46(3):198-20
Obesity-induced inflammation: a metabolic dialogue in the language of inflammationA. W. Ferrante JrFrom the Naomi Berrie Diabetes Center, Columbia University, New York, NY, USA Journal of Internal Medicine262; 408–414 2007
B.I. Ferreira, J.L. Abreu, J.P. Reis, A.M. Figueiredo, Psoriasis and associated psychiatric disorders: a systematic review on etiopathogenesis and clinical correlation, J. Clin. Aesthet. Dermatol. 9 (6) (2016) 36–43.
H. Devrimci-Ozguven, T.N. Kundakci, H. Kumbasar, A. Boyvat, The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients, J. Eur. Acad. Dermatol. Venereol. 14 (4) (2000) 267–271. 13 [12]
H.S. Moon, A. Mizara, S.R. McBride, Psoriasis and psycho-dermatology, Dermatol. Ther. (Heidelb.) 3 (2) (2013) 117–130.
J.M. Schmitt, D.E. Ford, Role of depression in quality of life for patients with psoriasis, Dermatology 215 (1) (2007) 17–27and adherence to psoriasis treatment
K.K. Wu, A.W. Armstrong, Suicidality among psoriasis patients: a critical evidence synthesis, G. Ital. Dermatol. Venereol. (2018).
L Punzi , M Podswiadek, F Oliviero, A Lonigro, V Modesti, R Ramonda, S Todesco, Laboratory findings in psoriatic arthritis, Reumatismo. 2007;59 Suppl 1:52-5. And cardiovascular deases
Cooksey R, Brophy S, Kennedy J, Gutierrez FF, Pickles T, Davies R, Piguet V, Choy E.Semin, Cardiovascular risk factors predicting cardiac events are different in patients with rheumatoid arthritis, psoriatic arthritis, and psoriasis.
Arthritis Rheum. 2018 Dec;48(3):367-373.
Fleming P , Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Siu S, Kraft J, Lynde C, Pope JE, Keeling S, Dutz J, Bessette L, Bissonnette R, Haraoui B, Gulliver WP. Effect of biologics on depressive symptoms in patients with psoriasis: a systematic review. J Eur Acad Dermatol Venereol. 2014 Dec 10.
Bayramgürler D, Karson A, Ozer C, Utkan T. Effects of long-term etanercept treatment on anxiety- and depression-like neurobehaviors in rats. Physiol Behav. 2013 Jul 2;119:145-8
Krishnan R, Cella D, Leonardi C, Papp K, Gottlieb AB, Dunn M, Chiou CF, Patel V, Jahreis A. Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96 weeks. Br J Dermatol. 2007 Dec;157(6):12757
Menter A, Augustin M, Signorovitch J, YuAP, Wu EQ, Gupta SR, BaoY, Mulani P. The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: a randomized clinical trial. Am Acad Dermatol. 2010 May;62(5):8128.
Langley RG , Feldman SR, Han C, Schenkel B, Szapary P, Hsu MC, Ortonne JP, Gordon KB, Kimball AB. Ustekinumab significantly improves symptoms of anxiety, depression, and skinrelated quality of life in patients with moderatetosevere psoriasis: Results from a randomized, doubleblind, placebocontrolled phase III trial. J Am Acad Dermatol. 2010 Sep;63(3):45765.
Bruce E Strober , New Therapies for Psoriasis, Semin Cutan Med Surg. 2016 Jun;35(4S):S71-S73.
Haider AS, Lowes MA, Suárez-Fariñas M, Zaba LC, Cardinale I, Khatcherian A, Novitskaya I, Wittkowski KM, Krueger JG. Identification of cellular pathways of "type 1," Th17 T cells, and TNF- and inducible nitric oxide synthase-producing dendritic cells in autoimmune inflammation through pharmacogenomic study of cyclosporine A in psoriasis. J Immunol. 2008 Feb 1;180(3):1913-20
Christoph Kraus et al, Serotonin and neuroplasticity – Links between molecular, functional and structural pathophysiology in depression, Neuroscience & Biobehavioral Reviews, Volume 77, June 2017, Pages 317-326
Nupur Patel , Anish Nadkarni , Leah A Cardwell , Nora Vera , Casey Frey , Nikhil Patel , Steven R Feldman , Psoriasis, Depression, and Inflammatory Overlap: A Review, Am J Clin Dermatol. 2017 Oct;18(5):613-620.
Danijel Crnković , Danijel Buljan, Dalibor Karlović, Marija Krmek, Connection between inflammatory markers, antidepressants and depression, Acta Clin Croat. 2012 Mar;51(1):25-33.
H.S. Moon, A. Mizara, S.R. McBride, Psoriasis and psycho-dermatology, Dermatol. Ther. (Heidelb.) 3 (2) (2013) 117–130.
A.C. Lavda, T.L. Webb, A.R. Thompson, A meta-analysis of the effectiveness of psychological interventions for adults with skin conditions, Br. J. Dermatol. 167 (5) (2012) 970–979.
N.L. Sin, S. Lyubomirsky, Enhancing well-being and alleviating depressive symptoms with positive psychology interventions: A practice-friendly metaanalysis, J. Clin. Psychol. 65 (5) (2009) 467–487
L. Bolier, M. Haverman, G.J. Westerhof, H. Riper, F. Smit, E. Bohlmeijer, Positive psychology interventions: a meta-analysis of randomized controlled studies, BMC Public Health 13 (2013) 119. https://doi.org/10.1186/1471-2458- 13-119.
D J Greenblatt, Elimination half-life of drugs: value and limitations, Annu Rev Med
. 1985;36:421-7. doi: 10.1146/annurev.me.36.020185.002225.
www.ema.europa.eu
Published
Issue
Section
License
Copyright (c) 2024 Eleni Mitsiou, Aikaterini Kyriakou, Eleni Parlapani, Anastasia Trigoni, Myrto Trakatelli, Zoe Apalla, Dimitrios Sotiriadis, Elizabeth Lazaridou, Aikaterini Patsatsi
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.
How to Cite
Share
